Research and Markets: Ragweed Allergy Pipeline Insights - Provides a Ragweed Allergy Landscape Across the Globe

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/mp5nc6/ragweed) has announced the addition of the "Ragweed Allergy-Pipeline Insights" report to their offering.

Ragweed Allergy- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Ragweed Allergy. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Ragweed Allergy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Ragweed Allergy- Pipeline Insights Report covers the Ragweed Allergy pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Ragweed Allergy related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Ragweed Allergy.

Scope

  • The report provides a Ragweed Allergy Landscape across the globe
  • The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
  • Coverage of the Ragweed Allergy pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Ragweed Allergy and also provide company profiling

Key Topics Covered:

  • Ragweed Allergy Overview
  • Ragweed Allergy Pipeline Therapeutics
  • Ragweed Allergy Therapeutics under Development by Companies
  • Ragweed Allergy Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Ragweed Allergy Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Ragweed Allergy Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Ragweed Allergy Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Ragweed Allergy - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Ragweed Allergy - Discontinued Products
  • Ragweed Allergy - Dormant Products
  • Companies Involved in Therapeutics Development for Ragweed Allergy

For more information visit http://www.researchandmarkets.com/research/mp5nc6/ragweed

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals